MLNT
Melinta Therapeutics, Inc. Common Stock
MLNT
MLNT
Delisted
MLNT was delisted on the 10th of January, 2020.
52 hedge funds and large institutions have $18.6M invested in Melinta Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
86% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 29
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
52
Holding in Top 10
–
Calls
$254K
Puts
$217K
Top Buyers
| 1 | +$7.38M | |
| 2 | +$1.03M | |
| 3 | +$592K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$544K |
| 5 |
ZIM
Zacks Investment Management
Chicago,
Illinois
|
+$542K |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$1.28M | |
| 3 | -$749K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$512K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$480K |